In contrast, type B3 thymomas and thymic carcinomas are characterized by an immune cell infiltrate of terminally differentiated T cells expressing either CD4 or CD8 [45,46], which may be more prone to mount an effective antitumoral response. The gene discussed is CD4; the disease is thymoma.